Many people view precision medicine as healthcare’s next frontier. The field promises a future where treatments are tailored to each patient’s unique genes, biology and disease risk, with the goal
A Daiichi Sankyo and AstraZeneca drug is now approved as a first-line treatment for a particularly difficult-to-treat type of breast cancer, bringing a new targeted therapy to patients that’s positioned
Private-label usually starts as a cost conversation. A branded product often costs more. A private-label option often costs less. On paper, both generally meet the spec. So why pay extra?
There is no shortage of innovation in healthcare. But what has been surprising is that despite all the innovation, it is still very difficult to navigate the healthcare system as
Pay attention to health tech for even a few weeks and you’ll spot the pattern. Amazon expanded its AI health assistant to anyone on its app or website. Microsoft rolled
Imagine two members receiving a message from their health plan on the same day. One is a 75-year-old Spanish-speaking man managing multiple chronic conditions. The other is a 30-year-old pregnant
The future of long-term care and rehabilitation will be determined by how intentionally we design systems around them. Too many organizations still treat workforce strain as a support issue when,
AI is everywhere in healthcare conversations right now, most of that discussion still sits at a high level. The real work is happening much closer to the ground, inside clinical
When it comes to health benefits, more attention has always been given to medical, compared with dental and vision. And yet, there is a growing recognition that oral health is
Most disputes between pharmaceutical companies and generic drugmakers end in settlements. Five years of class-action litigation over a Takeda Pharmaceutical gastrointestinal drug culminated this week in a jury awarding nearly $885
